• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过用在CD4+T细胞中形成颗粒介导的合胞体的能力替换包括源自缺陷颗粒的Env的区域来增强1型人类免疫缺陷病毒的感染性。

Enhancement of human immunodeficiency virus type 1 infectivity by replacing the region including Env derived from defective particles with an ability to form particle-mediated syncytia in CD4+T cells.

作者信息

Kinomoto Masanobu, Mukai Tetsu, Li Yong-Gang, Iwabu Yukie, Warachit Jiranan, Palacios J Alejandro, Ibrahim Madiha S, Tsuji Shoutaro, Goto Toshiyuki, Ikuta Kazuyoshi

机构信息

Department of Virology, Research Institute for Microbial Disease, Osaka University, 3-1 Yamadaoka, Suita, Osaka 565-0871, Japan.

出版信息

Microbes Infect. 2004 Aug;6(10):911-8. doi: 10.1016/j.micinf.2004.05.003.

DOI:10.1016/j.micinf.2004.05.003
PMID:15310467
Abstract

The infection and subsequent replication rates of human immunodeficiency virus type 1 (HIV-1) affect the pathogenicity. The initial stage of HIV-1 infection is largely regulated by viral envelope sequence. We previously reported that the defective doughnut-shaped particles produced from a persistently infected cell clone, named L-2, obtained from human CD4+ T-cell line MT-4 that was persistently infected with HIV-1 LAI strain, efficiently form particle-mediated syncytia with uninfected human CD4+ T-cell line, MOLT-4. Here, we prepared a molecular clone (pL2) containing the L-2 provirus to characterize the viral genetic region contributing to this activity to form particle-mediated syncytia. Several recombinants were constructed with pNL4-3 by replacing the pL2-derived region including full-length env. Characterization of the particles obtained by transfection with these recombinant clones confirmed that pL2-derived env carried the particle-mediated syncytia formation activity. It is noteworthy that the pL2-derived env region could also contribute to enhancement of infectivity in CD4+ T-cell lines as well as primary peripheral blood mononuclear cells (PBMCs). Thus, the HIV-1 particle-mediated syncytium formation activity could also contribute to the enhancement of HIV-1 infectivity.

摘要

1型人类免疫缺陷病毒(HIV-1)的感染及后续复制率会影响其致病性。HIV-1感染的初始阶段很大程度上受病毒包膜序列调控。我们之前报道过,从持续感染HIV-1 LAI毒株的人CD4+ T细胞系MT-4中获得的一个持续感染细胞克隆(命名为L-2)产生的有缺陷的甜甜圈状颗粒,能与未感染的人CD4+ T细胞系MOLT-4高效形成颗粒介导的多核巨细胞。在此,我们制备了一个包含L-2前病毒的分子克隆(pL2),以表征对这种形成颗粒介导的多核巨细胞活性有贡献的病毒基因区域。通过用包括全长env在内的pL2衍生区域替换pNL4-3构建了几个重组体。对用这些重组克隆转染获得的颗粒进行表征证实,pL2衍生的env具有颗粒介导的多核巨细胞形成活性。值得注意的是,pL2衍生的env区域也有助于增强在CD4+ T细胞系以及原代外周血单核细胞(PBMC)中的感染性。因此,HIV-1颗粒介导的多核巨细胞形成活性也可能有助于增强HIV-1的感染性。

相似文献

1
Enhancement of human immunodeficiency virus type 1 infectivity by replacing the region including Env derived from defective particles with an ability to form particle-mediated syncytia in CD4+T cells.通过用在CD4+T细胞中形成颗粒介导的合胞体的能力替换包括源自缺陷颗粒的Env的区域来增强1型人类免疫缺陷病毒的感染性。
Microbes Infect. 2004 Aug;6(10):911-8. doi: 10.1016/j.micinf.2004.05.003.
2
Characterization of an envelope mutant of HIV-1 that interferes with viral infectivity.一种干扰病毒感染性的HIV-1包膜突变体的特性分析。
Virology. 1996 Dec 15;226(2):260-8. doi: 10.1006/viro.1996.0654.
3
A monoclonal antibody to the gp120-CD4 complex has differential effect on HIV-induced syncytium formation and viral infectivity.一种针对gp120-CD4复合物的单克隆抗体对HIV诱导的合胞体形成和病毒感染性具有不同的影响。
J Gen Virol. 1995 Mar;76 ( Pt 3):669-79. doi: 10.1099/0022-1317-76-3-669.
4
Superinfection of defective human immunodeficiency virus type 1 with different subtypes of wild-type virus efficiently produces infectious variants with the initial viral phenotypes by complementation followed by recombination.1型人类免疫缺陷病毒缺陷株与不同亚型野生型病毒的双重感染通过互补和重组,有效地产生具有初始病毒表型的感染性变体。
Microbes Infect. 2008 Apr;10(5):504-13. doi: 10.1016/j.micinf.2008.01.012. Epub 2008 Feb 1.
5
Surface expression of the HIV-1 envelope proteins in env gene-transfected CD4-positive human T cell clones: characterization and killing by an antibody-dependent cellular cytotoxic mechanism.HIV-1包膜蛋白在env基因转染的CD4阳性人T细胞克隆中的表面表达:通过抗体依赖性细胞毒性机制进行表征和杀伤
J Acquir Immune Defic Syndr (1988). 1994 Aug;7(8):789-98.
6
Syncytium induction in primary CD4+ T-cell lines from normal donors by human immunodeficiency virus type 1 isolates with non-syncytium-inducing genotype and phenotype in MT-2 cells.在MT-2细胞中具有非合胞体诱导基因型和表型的1型人类免疫缺陷病毒分离株对来自正常供体的原代CD4 + T细胞系进行合胞体诱导。
J Virol. 1995 Nov;69(11):7099-105. doi: 10.1128/JVI.69.11.7099-7105.1995.
7
Mutations in the principal neutralization determinant of human immunodeficiency virus type 1 affect syncytium formation, virus infectivity, growth kinetics, and neutralization.1型人类免疫缺陷病毒主要中和决定簇的突变会影响合胞体形成、病毒感染性、生长动力学及中和作用。
J Virol. 1992 Apr;66(4):1875-83. doi: 10.1128/JVI.66.4.1875-1883.1992.
8
Syncytium formation induced by human immunodeficiency virus type 1 isolates correlates with affinity for CD4.1型人类免疫缺陷病毒分离株诱导的合胞体形成与对CD4的亲和力相关。
J Gen Virol. 1997 Oct;78 ( Pt 10):2513-22. doi: 10.1099/0022-1317-78-10-2513.
9
R5 HIV gp120-mediated cellular contacts induce the death of single CCR5-expressing CD4 T cells by a gp41-dependent mechanism.R5型HIV gp120介导的细胞接触通过gp41依赖性机制诱导单个表达CCR5的CD4 T细胞死亡。
J Leukoc Biol. 2004 Oct;76(4):804-11. doi: 10.1189/jlb.0204100. Epub 2004 Jul 16.
10
Production of infectious particles from defective human immunodeficiency virus type 1 (HIV-1)-producing cell clones by superinfection with infectious HIV-1.通过用感染性HIV-1进行超感染,从产生缺陷型1型人类免疫缺陷病毒(HIV-1)的细胞克隆中产生感染性颗粒。
Arch Virol. 1991;116(1-4):143-58. doi: 10.1007/BF01319238.

引用本文的文献

1
An HIV/AIDS Prophylactic vaccine is possible.一种预防艾滋病毒/艾滋病的疫苗是有可能研制出来的。
J Immune Based Ther Vaccines. 2007 Dec 19;5:12. doi: 10.1186/1476-8518-5-12.
2
Amino acid 36 in the human immunodeficiency virus type 1 gp41 ectodomain controls fusogenic activity: implications for the molecular mechanism of viral escape from a fusion inhibitor.人类免疫缺陷病毒1型gp41胞外结构域中的36位氨基酸控制融合活性:对病毒逃逸融合抑制剂分子机制的启示。
J Virol. 2005 May;79(10):5996-6004. doi: 10.1128/JVI.79.10.5996-6004.2005.